Allosteric pathways in nuclear receptors — Potential targets for drug design

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Pharmacology and Therapeutics

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.pharmthera.2017.10.014PMID 29080700PMCID PMC5817003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA‐induced unfolding of the thyroid hormone receptor α A/B domain through allostery

  2017cited by this paper
• The Promiscuity of Allosteric Regulation of Nuclear Receptors by Retinoid X Receptor.

  2016cited by this paper
• Mapping allostery through computational glycine scanning and correlation analysis of residue-residue contacts.

  2015cited by this paper
• Structural mechanism for signal transduction in RXR nuclear receptor heterodimers

  2015cited by this paper
• Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells.

  2015cited by this paper
• Identification of CAR/RXRα Hetero-dimer Binding Sites in the Human Genome by a Modified Yeast One-Hybrid Assay

  2015cited by this paper
• CINPA1 Is an Inhibitor of Constitutive Androstane Receptor That Does Not Activate Pregnane X Receptor

  2015cited by this paper
• The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors

  2015cited by this paper
• Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

  2015cited by this paper
• Structure of a biologically active estrogen receptor-coactivator complex on DNA.

  2015cited by this paper
• Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

  2014cited by this paper
• Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer

  2014cited by this paper
• Agonist Ligands Mediate the Transcriptional Response of Nuclear Receptor Heterodimers through Distinct Stoichiometric Assemblies with Coactivators*

  2014cited by this paper
• Nuclear Receptors, RXR, and the Big Bang.

  2014cited by this paper
• Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges.

  2014cited by this paper
• Nuclear receptor coactivators: master regulators of human health and disease.

  2014cited by this paper
• The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals

  2013cited by this paper
• Understanding nuclear receptor form and function using structural biology.

  2013cited by this paper
• Nuclear Receptors and Their Selective Pharmacologic Modulators

  2013cited by this paper
• Glucocorticoid receptor signaling in health and disease.

  2013cited by this paper
• Nuclear Corepressors Mediate the Repression of Phospholipase A2 Group IIa Gene Transcription by Thyroid Hormone*

  2013cited by this paper
• Regulation of the Structurally Dynamic N-terminal Domain of Progesterone Receptor by Protein-induced Folding*

  2013cited by this paper
• Role of Nuclear Receptor on Regulation of BDNF and Neuroinflammation in Hippocampus of β-Amyloid Animal Model of Alzheimer’s Disease

  2013cited by this paper
• Binding of the N-terminal Region of Coactivator TIF2 to the Intrinsically Disordered AF1 Domain of the Glucocorticoid Receptor Is Accompanied by Conformational Reorganizations*

  2012cited by this paper
• Steroid receptor coactivators 1, 2, and 3: critical regulators of nuclear receptor activity and steroid receptor modulator (SRM)-based cancer therapy.

  2012cited by this paper
• Structural and functional analysis of domains of the progesterone receptor.

  2012cited by this paper
• Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers

  2012cited by this paper
• PPARγ is a major driver of the accumulation and phenotype of adipose-tissue Treg cells

  2012cited by this paper
• Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors

  2012cited by this paper
• Nuclear receptor coregulators: modulators of pathology and therapeutic targets

  2012cited by this paper
• Evidence for DNA-Binding Domain–Ligand-Binding Domain Communications in the Androgen Receptor

  2012cited by this paper
• A comprehensive view of nuclear receptor cancer cistromes.

  2011cited by this paper
• Structural Dynamics, Intrinsic Disorder, and Allostery in Nuclear Receptors as Transcription Factors*

  2011cited by this paper
• Common architecture of nuclear receptor heterodimers on DNA direct repeat elements with different spacings

  2011cited by this paper
• Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor.

  2011cited by this paper
• Helix 11 dynamics is critical for constitutive androstane receptor activity.

  2011cited by this paper
• DNA binding alters coactivator interaction surfaces of the intact VDR–RXR complex

  2011cited by this paper
• SnapShot: Nuclear receptors II.

  2010cited by this paper
• SnapShot: Nuclear receptors I.

  2010cited by this paper
• Allosteric Effects Govern Nuclear Receptor Action: DNA Appears as a Player

  2009cited by this paper
• Dephosphorylation of Threonine 38 Is Required for Nuclear Translocation and Activation of Human Xenobiotic Receptor CAR (NR1I3)*

  2009cited by this paper
• Direct Interdomain Interactions Can Mediate Allosterism in the Thyroid Receptor*

  2009cited by this paper
• DNA Binding Site Sequence Directs Glucocorticoid Receptor Structure and Activity

  2009cited by this paper
• ChIP‐Seq of ERα and RNA polymerase II defines genes differentially responding to ligands

  2009cited by this paper
• Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated?

  2009cited by this paper
• Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA

  2008cited by this paper
• Thematic Review Series: Skin Lipids. Peroxisome proliferator-activated receptors and liver X receptors in epidermal biology Published, JLR Papers in Press, January 8, 2008.

  2008cited by this paper
• Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a.

  2008cited by this paper
• Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors

  2007cited by this paper
• Thermodynamic characterization of the interaction between CAR-RXR and SRC-1 peptide by isothermal titration calorimetry.

  2007cited by this paper
• The Ligand Binding Domain Controls Glucocorticoid Receptor Dynamics Independent of Ligand Release

  2007cited by this paper
• Thermodynamic analysis of progesterone receptor–promoter interactions reveals a molecular model for isoform-specific function

  2007cited by this paper
• Selective modulation of promoter recruitment and transcriptional activity of PPARgamma.

  2007cited by this paper
• A surface on the androgen receptor that allosterically regulates coactivator binding

  2007cited by this paper
• Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

  2006cited by this paper
• Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity.

  2006cited by this paper
• The Nuclear Receptor Superfamily and Drug Discovery

  2006cited by this paper
• International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D Receptor

  2006cited by this paper
• Regulation of Constitutive Androstane Receptor and Its Target Genes by Fasting, cAMP, Hepatocyte Nuclear Factor α, and the Coactivator Peroxisome Proliferator-activated Receptor γ Coactivator-1α*

  2006cited by this paper
• The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain.

  2006cited by this paper
• International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors

  2006cited by this paper
• Regulation of constitutive androstane receptor and its target genes by fasting, cAMP, hepatocyte nuclear factor alpha, and the coactivator peroxisome proliferator-activated receptor gamma coactivator-1alpha.

  2006cited by this paper
• Intra-domain communication between the N-terminal and DNA-binding domains of the androgen receptor: modulation of androgen response element DNA binding.

  2005cited by this paper
• Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling

  2005cited by this paper
• Characterization of activating signal cointegrator-2 as a novel transcriptional coactivator of the xenobiotic nuclear receptor constitutive androstane receptor.

  2005cited by this paper
• Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

  2005cited by this paper
• Structural determinants of allosteric ligand activation in RXR heterodimers.

  2004cited by this paper
• The Orphan Nuclear Receptor Constitutive Active/Androstane Receptor Is Essential for Liver Tumor Promotion by Phenobarbital in Mice

  2004cited by this paper
• Expression of Constitutive Androstane Receptor Splice Variants in Human Tissues and Their Functional Consequences

  2004cited by this paper
• The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity*

  2004cited by this paper
• Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor

  2004cited by this paper
• The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

  2004cited by this paper
• A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer.

  2004cited by this paper
• Meclizine is an agonist ligand for mouse constitutive androstane receptor (CAR) and an inverse agonist for human CAR.

  2004cited by this paper
• Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism.

  2004cited by this paper
• A Structural Basis for Constitutive Activity in the Human CAR/RXRα Heterodimer

  2004cited by this paper
• A Novel Distal Enhancer Module Regulated by Pregnane X Receptor/Constitutive Androstane Receptor Is Essential for the Maximal Induction of CYP2B6 Gene Expression*

  2003cited by this paper
• Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation.

  2003cited by this paper
• A nuclear receptor-mediated xenobiotic response and its implication in drug metabolism and host protection.

  2003cited by this paper
• Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state.

  2003cited by this paper
• Induction of bilirubin clearance by the constitutive androstane receptor (CAR)

  2003cited by this paper
• Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.

  2002cited by this paper
• Conformational Analysis of the Androgen Receptor Amino-terminal Domain Involved in Transactivation

  2002cited by this paper
• Modulation of Acetaminophen-Induced Hepatotoxicity by the Xenobiotic Receptor CAR

  2002cited by this paper
• Glucocorticoid Receptor-interacting Protein 1 Mediates Ligand-independent Nuclear Translocation and Activation of Constitutive Androstane Receptor in Vivo *

  2002cited by this paper
• A Structural Model of the Constitutive Androstane Receptor Defines Novel Interactions That Mediate Ligand-Independent Activity

  2002cited by this paper
• Phenobarbital response elements of cytochrome P450 genes and nuclear receptors.

  2001cited by this paper
• Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor α

  2001cited by this paper
• Allosteric modulation of estrogen receptor conformation by different estrogen response elements.

  2001cited by this paper
• The N-terminal Region of Human Progesterone B-receptors

  2001cited by this paper
• Nuclear Receptor Minireview Series*

  2001cited by this paper
• The Conformation of the Glucocorticoid Receptor AF1/tau1 Domain Induced by Osmolyte Binds Co-regulatory Proteins*

  2001cited by this paper
• Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha.

  2001cited by this paper
• Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.

  2000cited by this paper
• The N-terminal Region of the Human Progesterone A-receptor

  2000cited by this paper
• The coregulator exchange in transcriptional functions of nuclear receptors.

  2000cited by this paper
• The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism

  2000cited by this paper
• A unified nomenclature system for the nuclear receptor superfamily.

  1999cited by this paper
• Trimethylamine N-Oxide-induced Cooperative Folding of an Intrinsically Unfolded Transcription-activating Fragment of Human Glucocorticoid Receptor*

  1999cited by this paper
• A unified nomenclature system for the nuclear receptor superfamily

  1999cited by this paper

• NR4A1 Acts as a Novel Regulator of Platelet Activation and Thrombus Formation

  2025cites this paper
• Structural basis for the asymmetric binding of coactivator SRC1 to FXR-RXRα and allosteric communication within the complex

  2025cites this paper
• MD Multi-Sector Selector: Recursive Extraction and Refinement of Molecular Dynamics Based Sectors Yields Two Sectors in p53 Tumor Suppressor Protein

  2025cites this paper
• Nuclear receptors in health and disease: signaling pathways, biological functions and pharmaceutical interventions

  2025cites this paper
• Mutational landscapes of HNF MODY gene products display a wide distribution with functional implications

  2025cites this paper
• Conformational transition of a polycationic hinge domain contributes to DNA binding.

  2025cites this paper
• Asymmetric binding of coactivator SRC1 to FXR-RXR and allosteric communication within the complex

  2024cites this paper
• Hormone response elements for the thyroid receptor-α include specific distal 5′-flanking DNA

  2024cites this paper
• Nuclear receptors and other molecular targets in type 2 diabetes mellitus

  2023cites this paper
• Nontargeted Analysis Reveals a Broad Range of Bioactive Pollutants in Drinking Water by Estrogen Receptor Affinity-Mass Spectrometry.

  2023cites this paper
• ERRγ-DBD undergoes dimerization and conformational rearrangement upon binding to the downstream site of the DR1 element.

  2023cites this paper
• Design and Optimization of 1H-1,2,3-Triazole-4-carboxamides as Novel, Potent, and Selective Inverse Agonists and Antagonists of PXR.

  2022cites this paper
• Study of Human Albumin Protein Interaction with Fluorouracil Anticancer Drug Using Molecular Docking Method

  2022cites this paper
• Integrative analysis reveals structural basis for transcription activation of Nurr1 and Nurr1-RXRα heterodimer

  2022cites this paper
• Blockage of PPARγ T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions

  2022cites this paper
• Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family

  2022cites this paper
• Allosteric binding on nuclear receptors: Insights on screening of non-competitive endocrine-disrupting chemicals.

  2021cites this paper
• Residue-specific insights into (2x)72 kDa tryptophan synthase obtained from fast-MAS 1H-detected solid-state NMR

  2021cites this paper
• Advances in targeting ‘undruggable’ transcription factors with small molecules

  2021cites this paper
• Lycopene Preventing DEHP-Induced Renal Cell Damage Is Targeted by Aryl Hydrocarbon Receptor.

  2021cites this paper
• RXR – centralny regulator wielu ścieżek sygnałowych w organizmie

  2021cites this paper
• What Makes a Good Antagonist: Lessons Learned from the Estrogen and Aryl Hydrocarbon Receptors

  2021cites this paper
• Elucidation of an Allosteric Mode of Action for a Thienopyrazole RORγt Inverse Agonist

  2020cites this paper
• Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt

  2020cites this paper
• Allosteric small molecule modulators of nuclear receptors.

  2019cites this paper
• Revealing a Mutant-Induced Receptor Allosteric Mechanism for the Thyroid Hormone Resistance

  2019cites this paper
• Ligand-Induced Allosteric Effects Governing SR Signaling C .

  2019cites this paper
• Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease.

  2019cites this paper
• Ligand-Induced Allosteric Effects Governing SR Signaling

  2019cites this paper
• Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR

  2018cites this paper
• Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding

  2018cites this paper
• Ligand modulation of allosteric networks in an ancestral steroid receptor

  2018cites this paper
• Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1

  2018cites this paper